Latest news
Loading news…
Novelos Therapeutics, (Novelos) is a biopharmaceutical company focused on developing and commercializing oxidized glutathione-based
Novelos Therapeutics was acquired by Cellectar Biosciences in 2011 for $5M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Madison, Wisconsin, United States
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Novelos Therapeutics
Loading news…
FAQs about Novelos Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.